KRYS
$159.05
Revenue | $42.14Mn |
Net Profits | $8.69Mn |
Net Profit Margins | 20.63% |
Krystal Biotech Inc’s revenue jumped +Inf% since last year same period to $42.14Mn in the Q4 2023. On a quarterly growth basis, Krystal Biotech Inc has generated 392.55% jump in its revenue since last 3-months.
Krystal Biotech Inc’s net profit jumped 127.12% since last year same period to $8.69Mn in the Q4 2023. On a quarterly growth basis, Krystal Biotech Inc has generated -89.24% fall in its net profits since last 3-months.
Krystal Biotech Inc’s net profit margin jumped NaN% since last year same period to 20.63% in the Q4 2023. On a quarterly growth basis, Krystal Biotech Inc has generated -97.81% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.08 |
EPS Estimate Current Year | 0.08 |
Krystal Biotech Inc’s earning per share (EPS) estimates for the current quarter stand at 0.08 - a 121.05% jump from last quarter’s estimates.
Krystal Biotech Inc’s earning per share (EPS) estimates for the current year stand at 0.08.
Earning Per Share (EPS) | 0.3 |
Krystal Biotech Inc’s earning per share (EPS) jumped 124% since last year same period to 0.3 in the Q4 2023. This indicates that the Krystal Biotech Inc has generated 124% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-08-07 | -0.74 | -1.25 | -68.92% |
2023-11-06 | -0.29 | -0.69 | -137.93% |
2024-02-26 | -0.38 | 0.3 | 178.95% |
2023-05-08 | -1.44 | -1.76 | -22.22% |